NCT03743116

Brief Summary

Incidence of Postoperative Orthostatic Intolerance and Postoperative Orthostatic Hypotension in Patients Undergoing Unilateral Total Knee Arthroplasty

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

November 13, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 15, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

August 30, 2022

Status Verified

August 1, 2022

Enrollment Period

8 months

First QC Date

November 8, 2018

Last Update Submit

August 29, 2022

Conditions

Keywords

Orthostatic IntoleranceOrthostatic HypotensionKnee arthroplasty

Outcome Measures

Primary Outcomes (2)

  • Incidence of orthostatic intolerance

    Symptoms of orthostatic intolerance: dizziness, nausea, vomiting, blurry vision or syncope during mobilization

    6 hours postoperatively

  • Incidence of orthostatic hypotension

    Orthostatic hypotension is defined as a fall in systolic pressure \> 20 mmHg and/or diastolic pressure \> 10 mmHg during mobilization

    6 hours postoperatively

Secondary Outcomes (6)

  • Changes in systolic arterial pressure (SAP) during mobilization

    Preoperatively, 6 and 24 hours postoperatively

  • Changes in diastolic arterial pressure (DAP) during mobilization

    Preoperatively, 6 and 24 hours postoperatively

  • Changes in mean arterial pressure (MAP) during mobilization

    Preoperatively, 6 and 24 hours postoperatively

  • Changes in systemic vascular resistance (SVR) during mobilization

    Preoperatively, 6 and 24 hours postoperatively

  • Changes in cardiac output (CO) during mobilization

    Preoperatively, 6 and 24 hours postoperatively

  • +1 more secondary outcomes

Study Arms (2)

Orthostatic intolerant (OI)

Patients that experience symptoms of orthostatic intolerance (dizziness, nausea, vomiting, blurry vision or syncope) or orthostatic hypotension (fall in systolic pressure \> 20 mmHg and/or diastolic pressure \> 10 mmHg) during mobilisation

Orthostatic tolerant (OT)

Patients that do not experience symptoms of orthostatic intolerance (dizziness, nausea, vomiting, blurry vision or syncope) or orthostatic hypotension (fall in systolic pressure \> 20 mmHg and/or diastolic pressure \> 10 mmHg) during mobilisation

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing primary unilateral total knee arthroplasty in spinal anesthesia and standardized fast-track setting

You may qualify if:

  • Age ≥ 18
  • Written informed consent
  • Patients that speak and understand Danish
  • Patients undergoing primary unilateral total knee arthroplasty in spinal anesthesia and standardized fast-track setting

You may not qualify if:

  • Alcohol or drug abuse
  • Cognitive dysfunction
  • Known orthostatic hypotension
  • Use of anxiolytic drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hvidovre University Hosptial

Copenhagen, Denmark

Location

MeSH Terms

Conditions

Orthostatic IntoleranceHypotension, OrthostaticPostoperative Complications

Condition Hierarchy (Ancestors)

Primary DysautonomiasAutonomic Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHypotensionVascular DiseasesCardiovascular DiseasesPathologic Processes

Study Officials

  • Ana-Marija Hristovska, MD

    Department of Anesthesiology, Hvidovre Hospital, Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Medical Doctor

Study Record Dates

First Submitted

November 8, 2018

First Posted

November 15, 2018

Study Start

November 13, 2018

Primary Completion

July 1, 2019

Study Completion

March 1, 2020

Last Updated

August 30, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations